Cargando…
Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
The advent of biologics and biologic therapy has transformed the management of inflammatory bowel disease (IBD) with enhanced early and adequate responses to treatment, fewer hospitalizations, a reduced need for surgery, and unprecedented outcomes including complete mucosal and histologic healing. H...
Autores principales: | Banerjee, Rupa, Ali, Raja Affendi Raja, Wei, Shu Chen, Adsul, Shashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667923/ https://www.ncbi.nlm.nih.gov/pubmed/33191310 http://dx.doi.org/10.5009/gnl19209 |
Ejemplares similares
-
Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease
por: Chew, Deborah, et al.
Publicado: (2018) -
The Positive Influences of Increasing Age at Diagnosis of Inflammatory Bowel Disease on Disease Prognostication in Asian Perspective
por: Ali, Raja Affendi Raja
Publicado: (2015) -
Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place
por: Abdul Rani, Rafiz, et al.
Publicado: (2016) -
Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future
por: Zhiqin, Wong, et al.
Publicado: (2014) -
Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence
por: Chan, Seow-Neng, et al.
Publicado: (2018)